About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

HMNC Brain Health to Present Advances in Precision Psychiatry and Psychedelics at CNS Summit 2024 in Boston

MUNICH, Oct. 31, 2024 (GLOBE NEWSWIRE) -- HMNC Brain Health (or “HMNC”), a clinical-stage precision psychiatry biopharma company, pioneering the development of personalized therapies powered by predictive companion diagnostics, today announced its participation at CNS Summit, the leading life sciences gathering, taking place from November 10-13, 2024, in Boston, Massachusetts. This year’s event brings together the leading minds in the life sciences, and HMNC Brain Health will play a pivotal role in two key discussions shaping the future of precision psychiatry and psychedelics.

Panel: Dr. Hans Eriksson, Chief Medical Officer at HMNC Brain Health, will join a panel to discuss the future of psychedelics in mental health care. The panel, “Psychedelic Forum Spotlight Session,” will be held on Tuesday, November 12, 2024, from 1:00 to 1:50 PM ET in session room Renoir 1/2. Alongside other industry leaders, Dr. Eriksson will delve into breakthrough innovations and the regulatory landscape that could transform the treatment for conditions such as depression and PTSD. Joining him on this panel are:

  • Kabir Nath, Co-CEO, Compass Pathways (Chair)
  • Srinivas Rao, Chief Scientific Officer, Atai Life Sciences
  • Dan Karlin, Chief Medical Officer, MindMed

This panel will address pressing questions about commercial viability, safety profiles, and next steps for psychedelics in mainstream treatment options, giving investors and industry insiders a glimpse into what’s next for this evolving field.

Poster Presentation: In a significant showcase of its precision psychiatry advancements, Dr. Daniel Gehrlach, Associate Director of Biomarkers at HMNC Brain Health, will present research that could redefine treatment pathways for mental health disorders. His poster, titled “Precision Psychiatry with Co-Development of Genetic Companion Diagnostics: A Novel Approach for Clinical Development,” will be presented on:

  • Date: Monday, November 11, 2024
  • Time: 5:00 to 7:00 PM ET
  • Poster Number: 28

Dr. Gehrlach’s presentation will unveil HMNC’s innovative use of genetic companion diagnostics to guide psychiatric treatments for individual patients, a step that promises to significantly increase efficacy and reduce trial-and-error in mental health therapies. This poster will highlight HMNC’s methods in developing personalized treatments for Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).

Together, these presentations underscore HMNC Brain Health’s leadership at the intersection of neuroscience, precision medicine, and next-generation psychiatric treatments.

To schedule a one-on-one meeting with HMNC’s management team during the CNS Summit, please contact HMNCBrain@kcsa.com.

About HMNC Brain Health
HMNC Brain Health (HMNC Holding GmbH) is a global precision psychiatry biopharma company headquartered in Munich, Germany, pioneering the development of personalized therapies powered by predictive companion diagnostics, leading to higher remission rates. The company develops a unique pipeline targeting both Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD). With a presence in both Germany and the U.S., HMNC is backed by renowned global venture capital firms, family offices, and strategic healthcare investors. For more information, visit www.hmnc-brainhealth.com.

About CNS Summit
CNS Summit is a multi-therapeutic, executive community of life sciences innovators and industry leaders devoted to discovering better, more efficient ways to develop new treatments for patients. Developed by the life sciences industry, for the life sciences industry, CNS Summit is a year-round, worldwide community that convenes each November in Boston for four days.

Media Contact (U.S.):
Anne Donohoe
(732) 620-0033
hmncbrain@kcsa.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.